Real-world claims data and tissue culture studies set the stage for randomized clinical testing
Recognizing this association aids risk assessment before starting novel immunotherapies
Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches
Novel research is comparing sleep measures to biomarkers of neurodegeneration
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
High plasma ApoA1 and TG/HDL-C ratio predict faster progression
New research explores the role of immune cell and blood-brain barrier changes
Open-source artificial intelligence technology uses human genetic data to find candidate drugs
Experts weigh in on the amyloid hypothesis and how to use lecanemab if approved
Findings underscore need for racial diversity in ongoing and future trials
Investigative highlights include hormone therapies, biomarkers and early lifestyle interventions